SCHEMBL4178829

SCHEMBL4178829

Cc1cc2cc(n1)NCCCCOCCC(C)CCNC2=O

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.36
HSP90AA1 P07900 2/20 0.31
MAPK1 P28482 1/20 0.31
LRRK2 Q5S007 1/20 0.31
IRAK1 P51617 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4651945 0.70 BACE1 (0.53) BACE1HSP90AA1
SCHEMBL14803908 0.61
Tetrahydrofuran SCHEMBL21484246 0.60 ALDH1A1 (0.50)
SCHEMBL19094346 0.57
SCHEMBL18800937 0.55 PARP1 (0.38) HSP90AA1
SCHEMBL11696421 0.55 ALDH1A1 (0.42)
SCHEMBL5945183 0.55
SCHEMBL8217464 0.55
SCHEMBL12514 0.54
Ammonia Solution, Strong SCHEMBL524134 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046761-A2 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS Novartis AG (CH) 2009-04-15 EP disclosed
WO-2008009750-A2 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2008-01-24 WO disclosed